Current year publications

2023
2023 Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity Bonomo, R., Canta, A., Chiorazzi, A., Carozzi, V., Meregalli, C., Pozzi, E., et al. (2023). Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity. Intervento presentato a: 76TH MEETING of the Italian Society of Anatomy and Histology, MODENA.2023 Microtubule stabilisation and mitochondrial dysfunctions as axonal degeneration mechanisms in bortezomib-treated sensory neurons Meregalli, C., Malacrida, A., Pero, M., Rumora, A., Cartelli, D., Nicolini, G., et al. (2023). Microtubule stabilisation and mitochondrial dysfunctions as axonal degeneration mechanisms in bortezomib-treated sensory neurons. In 76° CONGRESSOdella Società Italiana di Anatomia e Istologia (pp.28-28). FIRENZE UNIVERSITY PRESS.2023 HDAC inhibitors as antineoplastic and neuroprotective drugs: in vitro assessment Squarzoni, A., Alberti, P., Donzelli, E., Scuteri, A., Cavaletti, G. (2023). HDAC inhibitors as antineoplastic and neuroprotective drugs: in vitro assessment. In Abstract book.2023 EXPLOITING HDAC6 SPECIFIC INHIBITORS TO REDUCE OHP-INDUCED NEUROTOXICITY Squarzoni, A., Donzelli, E., Alberti, P., Ballarini, E., Rodriguez Menendez, V., Scuteri, A., et al. (2023). EXPLOITING HDAC6 SPECIFIC INHIBITORS TO REDUCE OHP-INDUCED NEUROTOXICITY. In PNS Abstracts 2023 (pp.141-142) [10.1111/jns.12585].2023 NOVEL HIGH-RESOLUTION-APPROACHES TO STUDY THE VASCULAR NETWORKS IN THE PERIPHERAL NERVOUS SYSTEM OF RATS WITH CISPLATIN-INDUCED PERIPHERAL NEUROTOXICITY Carozzi, V., Rodriguez-Menendez, V., Bossi, M., Meregalli, C., Marmiroli, P., Cavaletti, G., et al. (2023). NOVEL HIGH-RESOLUTION-APPROACHES TO STUDY THE VASCULAR NETWORKS IN THE PERIPHERAL NERVOUS SYSTEM OF RATS WITH CISPLATIN-INDUCED PERIPHERAL NEUROTOXICITY. Intervento presentato a: Peripheral Nerve Society, Copenhagen, Denmark.2023 CIPN and its mechanism of development Tarasiuk, O., Pozzi, E., Canta, A., Chiorazzi, A., Ballarini, E., Rodriguez-Menendez, V., et al. (2023). CIPN and its mechanism of development. In Proceedings of the 33rd National Conference of the Italian Group for the Study of Neuromorphology “Gruppo Italiano per lo Studio della Neuromorfologia” G.I.S.N. November 24-25, 2023, University of Verona, Verona - Italy (pp.13-13). Pavia : PAGEPress.2023 CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome Al-Hakem, H., Doets, A., Stino, A., Zivkovic, S., Andersen, H., Willison, H., et al. (2023). CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome. NEUROLOGY, 100(23), 2386-2397 [10.1212/WNL.0000000000207282].2023 Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials Schilke, E., Remoli, G., Funelli, E., Galimberti, M., Fusco, M., Cereda, D., et al. (2023). Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials. NEUROLOGICAL SCIENCES [10.1007/s10072-023-07228-3].2023 Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy Li, Y., Drabison, T., Nepal, M., Ho, R., Leblanc, A., Gibson, A., et al. (2023). Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy. JCI INSIGHT, 8(14) [10.1172/jci.insight.164646].2023 Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy Cavaletti, G., Pizzamiglio, C., Man, A., Engber, T., Comi, C., Wilbraham, D. (2023). Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy. CANCERS, 15(17) [10.3390/cancers15174216].2023 Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register Mosconi, P., Guerra, T., Paletta, P., D'Ettorre, A., Ponzio, M., Battaglia, M., et al. (2023). Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register. NEUROLOGICAL SCIENCES, 44(11), 4001-4011 [10.1007/s10072-023-06876-9].2023 Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy Doneddu, P., Akyil, H., Manganelli, F., Briani, C., Cocito, D., Benedetti, L., et al. (2023). Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy. JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY, 94(8), 614-621 [10.1136/jnnp-2022-331011].2023 Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity Bonomo, R., Canta, A., Chiorazzi, A., Carozzi, V., Meregalli, C., Pozzi, E., et al. (2023). Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 29(1), 58-71 [10.1111/jns.12609].2023 Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy Pozzi, E., Rodriguez-Menendez, V., Ballarini, E., Argentini, A., Canta, A., Chiorazzi, A., et al. (2023). Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy. In Proceedings of the 33rd National Conference of the Italian Group for the Study of Neuromorphology “Gruppo Italiano per lo Studio della Neuromorfologia” G.I.S.N., Verona, November 24-25, 2023 (pp.14-15). PAGEPress.2023 Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing Chiorazzi, A., Canta, A., Carozzi, V., Meregalli, C., Pozzi, E., Ballarini, E., et al. (2023). Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM [10.1111/jns.12607].2023 Oxaliplatin neurotoxicity: morpho-functional approach Alberti, P., Pozzi, E., Serra, M., Trucas, M., Boi, M., Capelli, C., et al. (2023). Oxaliplatin neurotoxicity: morpho-functional approach. In Abstract book.2023 TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells Cordani, N., Mologni, L., Piazza, R., Tettamanti, P., Cogliati, V., Mauri, M., et al. (2023). TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(22) [10.3390/ijms242216294].2023 Customization of LC-MS-based proteomic workflows for biological studies in the clinical field Pagani, L., Previtali, P., Chinello, C., Capitoli, G., Risca, G., Radice, A., et al. (2023). Customization of LC-MS-based proteomic workflows for biological studies in the clinical field. Intervento presentato a: Annual PhD Conference in Biomedical Sciences, Monza, Italy.2023 Gait analysis in chemotherapy-induced peripheral neurotoxicity rodent models Lopez-Garzon, M., Canta, A., Chiorazzi, A., Alberti, P. (2023). Gait analysis in chemotherapy-induced peripheral neurotoxicity rodent models. BRAIN RESEARCH BULLETIN, 203(15 October 2023) [10.1016/j.brainresbull.2023.110769].2023 Role of Mouse Organic Cation Transporter 2 for Nephro- and Peripheral Neurotoxicity Induced by Chemotherapeutic Treatment with Cisplatin Hucke, A., Schröter, R., Ceresa, C., Chiorazzi, A., Canta, A., Semperboni, S., et al. (2023). Role of Mouse Organic Cation Transporter 2 for Nephro- and Peripheral Neurotoxicity Induced by Chemotherapeutic Treatment with Cisplatin. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(14), 1-18 [10.3390/ijms241411486].2023 Oxaliplatin Induced Peripheral Neurotoxicity: From Bed to Bench Side and Vice Versa Alberti, P. (2023). Oxaliplatin Induced Peripheral Neurotoxicity: From Bed to Bench Side and Vice Versa. In Abstract book.2023 High resolution MRI in exploring peripheral nerve anatomy and axonal damage in rodent models Alberti, P., Mastropietro, A., Rizzo, G., Taccogna, M., Bontempi, P., Schiavi, S., et al. (2023). High resolution MRI in exploring peripheral nerve anatomy and axonal damage in rodent models. In Abstract book.2023 Effect of nonlinear exercise program through mHealth System (ATOPE+) on isokinetic strenght in patients with breast cancer undergoing medical treatments Lopez-Garzon, M., Alberti, P., Postigo-Martin, P., Gonzàlez-Santos, A., Gilgutiérrez, R., Salinas-Asensio, M., et al. (2023). Effect of nonlinear exercise program through mHealth System (ATOPE+) on isokinetic strenght in patients with breast cancer undergoing medical treatments. In Abstract book.2023 Peripheral Neurotoxic Medications in CMT Patients Cavaletti, G., Forsey, K., Alberti, P. (2023). Peripheral Neurotoxic Medications in CMT Patients. In Meeting proceedings.2023 Acute and chronic Oxaliplatin-induced peripheral neurotoxicity: two sides of the same coin Alberti, P., Canta, A., Chiorazzi, A., Pozzi, E., Ballarini, E., Rodriguez-Menendez, V., et al. (2023). Acute and chronic Oxaliplatin-induced peripheral neurotoxicity: two sides of the same coin. In Meeting proceedings.2023 Chemotherapy-induced peripheral neurotoxicity (CIPN): why should we care? Alberti, P., Lucchese, E. (2023). Chemotherapy-induced peripheral neurotoxicity (CIPN): why should we care?. In Meeting proceedings.2023 Histone deacetylases inhibitors: a new frontier for neuroprotection? Squarzoni, A., Donzelli, E., Alberti, P., Ballarini, E., Rodriguez Menendez, V., Scuteri, A., et al. (2023). Histone deacetylases inhibitors: a new frontier for neuroprotection?. In Abstracts of the Thirteenth Annual Meeting of the Italian Association for the study of the Peripheral Nervous System (ASNP), 25-27 May 2023, Naples, Italy (pp.46-46). WILEY [10.1111/jns.12550].2023 Toxic Medications in Charcot-Marie-Tooth Patients: A Systematic Review Cavaletti, G., Forsey, K., Alberti, P. (2023). Toxic Medications in Charcot-Marie-Tooth Patients: A Systematic Review. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 28(3 (September 2023)), 295-307 [10.1111/jns.12566].2023 CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY (CIPN): SOCIO-ECONOMIC BURDEN – A PILOT STUDY Alberti, P., Lucchese, E. (2023). CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY (CIPN): SOCIO-ECONOMIC BURDEN – A PILOT STUDY. In Abstracts of the Thirteenth Annual Meeting of the Italian Association for the study of the Peripheral Nervous System (ASNP), 25-27 May 2023, Naples, Italy (pp.4-5). Wiley-Blackwell Publishing, Inc. [10.1111/jns.12550].2023 REFINEMENT OF MORPHOLOGICAL ANALYSIS OF THE CAUDAL NERVE IN A RODENT MODEL OF AXONAL DAMAGE WITH 7T MRI Alberti, P., Mastropietro, A., Rizzo, G., Taccogna, M., Bontempi, P., Schiavi, S., et al. (2023). REFINEMENT OF MORPHOLOGICAL ANALYSIS OF THE CAUDAL NERVE IN A RODENT MODEL OF AXONAL DAMAGE WITH 7T MRI. In Abstracts of the Thirteenth Annual Meeting of the Italian Association for the study of the Peripheral Nervous System (ASNP), 25-27 May 2023, Naples, Italy (pp.3-3). Wiley-Blackwell Publishing, Inc. [10.1111/jns.12550].2023 Framework to leverage physical therapists for the assessment and treatment of chemotherapy-induced peripheral neurotoxicity (CIPN) Stoller, S., Capozza, S., Alberti, P., Lustberg, M., Kleckner, I. (2023). Framework to leverage physical therapists for the assessment and treatment of chemotherapy-induced peripheral neurotoxicity (CIPN). SUPPORTIVE CARE IN CANCER, 31(5) [10.1007/s00520-023-07734-2].2023 Self-Reported Assessment of the Socio-Economic Impact of Anticancer Chemotherapy-Related Neurotoxicity Cavaletti, G., D'Acunti, A., Porcu, A., Masiello, G., Del Campo, L., Traclo, G., et al. (2023). Self-Reported Assessment of the Socio-Economic Impact of Anticancer Chemotherapy-Related Neurotoxicity. TOXICS, 11(2) [10.3390/toxics11020104].2023 Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence Park, S., Cetinkaya-Fisgin, A., Argyriou, A., Höke, A., Cavaletti, G., Alberti, P. (2023). Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence. JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY, 94(11), 962-972 [10.1136/jnnp-2021-328323].2023 Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells Cordani, N., Mologni, L., Piazza, R., Cogliati, V., Pepe, F., Capici, S., et al. (2023). Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells. In Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX (pp.13-21). AACR [10.1158/1538-7445.SABCS22-P1-13-21].2023 Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity Dionisi, M., Riva, B., Delconti, M., Meregalli, C., Chiorazzi, A., Canta, A., et al. (2023). Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity. SCIENTIFIC REPORTS, 13(1) [10.1038/s41598-023-31095-9].2023 Editorial: Tubulin and axonal transport disturbances in CNS and PNS diseases Bartolini, F., Cavaletti, G. (2023). Editorial: Tubulin and axonal transport disturbances in CNS and PNS diseases. EXPERIMENTAL NEUROLOGY, 362(April 2023) [10.1016/j.expneurol.2023.114343].2023 Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats Canta, A., Carozzi, V., Chiorazzi, A., Meregalli, C., Oggioni, N., Rodriguez-Menendez, V., et al. (2023). Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats. BIOMEDICINES, 11(1) [10.3390/biomedicines11010020].2023 Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent Malacrida, A., Deschamps-Wright, M., Rigolio, R., Cavaletti, G., Miloso, M. (2023). Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(2) [10.3390/ijms24021721].2023 Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration De Santo, M., Giovinazzo, A., Fava, M., Mazzotta, E., De Napoli, I., Greco, M., et al. (2023). Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration. MATERIALS CHEMISTRY FRONTIERS, 7(2), 216-229 [10.1039/d2qm01009g].2023 Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity Pozzi, E., Ballarini, E., Rodriguez Menendez, V., Canta, A., Chiorazzi, A., Monza, L., et al. (2023). Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity. TOXICS, 11(2), 1-19 [10.3390/toxics11020093].2023 Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy Pozzi, E., Monza, L., Ballarini, E., Bossi, M., Rodriguez-Menendez, V., Canta, A., et al. (2023). Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(2) [10.3390/ijms24021687].2023 Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses Benincasa, L., Molesti, E., Manenti, A., Montomoli, E., Malacrida, A., Zuliani, V., et al. (2023). Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses. LETTERS IN DRUG DESIGN & DISCOVERY, 20(10), 1656-1663 [10.2174/1570180819666220701105250].
2022
2022 MITOCHONDRIAL DYSFUNCTION IS A FEATURE OF PACLITAXEL AND OXALIPLATIN-PROMOTED CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY Giatti, S., Pero, M., Meregalli, C., Dioniso, M., Monza, L., Alberti, P., et al. (2022). MITOCHONDRIAL DYSFUNCTION IS A FEATURE OF PACLITAXEL AND OXALIPLATIN-PROMOTED CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY. In Abstracts of the 2022 Peripheral Nerve Society Annual Meeting (pp.51-52). WILEY.2022 CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS Semperboni, S., Malacrida, A., Rumora, A., Cartelli, D., Monza, L., Pero, M., et al. (2022). CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS. In Abstracts of the 2022 Peripheral Nerve Society Annual Meeting (pp.96-96). Wiley.2022 UNVEILING THE MICROVASCULAR NETWORK ALTERATIONS IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF RATS EXPOSED TO NEUROTOXIC CHEMOTHERAPY Carozzi, V., Pozzi, E., Monza, L., Rodriguez-Menendez, V., Ballarini, E., Canta, A., et al. (2022). UNVEILING THE MICROVASCULAR NETWORK ALTERATIONS IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF RATS EXPOSED TO NEUROTOXIC CHEMOTHERAPY. In Annual Meeting of the Peripheral-Nerve-Society (pp.158-159). WILEY.2022 A mechanistic understanding of the relationship between skin innervation and chemotherapy-induced neuropathic pain Meregalli, C., Monza, L., Jongen, J. (2022). A mechanistic understanding of the relationship between skin innervation and chemotherapy-induced neuropathic pain. FRONTIERS IN PAIN RESEARCH, 3 [10.3389/fpain.2022.1066069].2022 Exploiting the double-effect of HDACi as therapeutic tool against cancer Squarzoni, A., Donzelli, E., Alberti, P., Scuteri, A., Cavaletti, G. (2022). Exploiting the double-effect of HDACi as therapeutic tool against cancer. Intervento presentato a: NeuroMI 2022 Annual Meeting, Milano, Italia.2022 Evaluation of antitumoral effect of Hibiscus sabdariffa extract on human breast cancer cells Malacrida, A., Erriquez, J., Hashemi, M., Rodriguez-Menendez, V., Cassetti, A., Cavaletti, G., et al. (2022). Evaluation of antitumoral effect of Hibiscus sabdariffa extract on human breast cancer cells. BIOCHEMISTRY AND BIOPHYSICS REPORTS, 32(December 2022) [10.1016/j.bbrep.2022.101353].2022 Neurological Complications of Conventional and Novel Anticancer Treatments Alberti, P., Salvalaggio, A., Argyriou, A., Bruna, J., Visentin, A., Cavaletti, G., et al. (2022). Neurological Complications of Conventional and Novel Anticancer Treatments. CANCERS, 14(24) [10.3390/cancers14246088].2022 From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells Listro, R., Malacrida, A., Ambrosio, F., Rossino, G., Di Giacomo, M., Cavalloro, V., et al. (2022). From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23(21) [10.3390/ijms232113061].2022 K index utility as diagnostic and prognostic biomarker in the assessment of patients with suspected Multiple Sclerosis Cutelle, C., Balducci, C., Cereda, D., Fusco, M., Iacobucci, D., Perugini, J., et al. (2022). K index utility as diagnostic and prognostic biomarker in the assessment of patients with suspected Multiple Sclerosis. JOURNAL OF NEUROIMMUNOLOGY, 373(15 December 2022) [10.1016/j.jneuroim.2022.577992].2022 Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients with Primary Progressive Multiple Sclerosis Portaccio, E., Fonderico, M., Iaffaldano, P., Pasto, L., Razzolini, L., Bellinvia, A., et al. (2022). Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients with Primary Progressive Multiple Sclerosis. JAMA NEUROLOGY, 79(9), 869-878 [10.1001/jamaneurol.2022.1929].2022 Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register Bergamaschi, R., Beghi, E., Bosetti, C., Ponzio, M., Santucci, C., Lepore, V., et al. (2022). Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register. NEUROLOGICAL SCIENCES, 43(9), 5459-5469 [10.1007/s10072-022-06169-7].2022 Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M) Pfeiffer, P., Lustberg, M., Näsström, J., Carlsson, S., Persson, A., Nagahama, F., et al. (2022). Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M). JNCI CANCER SPECTRUM, 6(6) [10.1093/jncics/pkac075].2022 ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe Vaz-Luis, I., Masiero, M., Cavaletti, G., Cervantes, A., Chlebowski, R., Curigliano, G., et al. (2022). ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe. ANNALS OF ONCOLOGY, 33(11), 1119-1133 [10.1016/j.annonc.2022.07.1941].2022 AMPK and Diseases: State of the Art Regulation by AMPK-Targeting Molecules Tarasiuk, O., Miceli, M., Di Domizio, A., Nicolini, G. (2022). AMPK and Diseases: State of the Art Regulation by AMPK-Targeting Molecules. BIOLOGY, 11(7) [10.3390/biology11071041].2022 HDACi: The Columbus’ Egg in Improving Cancer Treatment and Reducing Neurotoxicity? Squarzoni, A., Scuteri, A., Cavaletti, G. (2022). HDACi: The Columbus’ Egg in Improving Cancer Treatment and Reducing Neurotoxicity?. CANCERS, 14(21) [10.3390/cancers14215251].2022 NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity Alberti, P., Ballarini, E., Malacrida, A., Pozzi, E., Rodriguez-Menendez, V., Monza, L., et al. (2022). NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity. In NeuroMI 2022 - Meeting proceedings.2022 Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neurotoxicity Pozzi, E., Alberti, P. (2022). Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neurotoxicity. In Q. Yan (a cura di), Pharmacogenomics in Drug Discovery and Development (pp. 95-140). Humana Press, Inc. [10.1007/978-1-0716-2573-6_5].2022 Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? Ballarini, E., Malacrida, A., Rodriguez Menendez, V., Pozzi, E., Canta, A., Chiorazzi, A., et al. (2022). Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage?. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23(17), 1-18 [10.3390/ijms231710063].2022 Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin Alberti, P., Ballarini, E., Malacrida, A., Pozzi, E., Rodriguez-Menendez, V., Monza, L., et al. (2022). Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin. Intervento presentato a: 75° congresso nazionale della Società di Anatomia e Istologia, Padova, Italy.2022 Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy Alberti, P., Pozzi, E., Monza, L., Chiorazzi, A., Canta, A., Ballarini, E., et al. (2022). Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy. Intervento presentato a: 75° Congresso Nazionale della Società Italiana di Anatomia e Istologia, Padova, Italy.2022 Neurons: The Interplay between Cytoskeleton, Ion Channels/Transporters and Mitochondria Alberti, P., Semperboni, S., Cavaletti, G., Scuteri, A. (2022). Neurons: The Interplay between Cytoskeleton, Ion Channels/Transporters and Mitochondria. CELLS, 11(16) [10.3390/cells11162499].2022 Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics Taiarol, L., Bigogno, C., Sesana, S., Kravicz, M., Viale, F., Pozzi, E., et al. (2022). Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics. CANCERS, 14(12) [10.3390/cancers14122978].2022 Ubiquitin Proteasome System and Microtubules Are Master Regulators of Central and Peripheral Nervous System Axon Degeneration Cartelli, D., Cavaletti, G., Lauria, G., Meregalli, C. (2022). Ubiquitin Proteasome System and Microtubules Are Master Regulators of Central and Peripheral Nervous System Axon Degeneration. CELLS, 11(8) [10.3390/cells11081358].2022 Making Connections: Mesenchymal Stem Cells Manifold Ways to Interact with Neurons Tarasiuk, O., Ballarini, E., Donzelli, E., Rodriguez-Menendez, V., Bossi, M., Cavaletti, G., et al. (2022). Making Connections: Mesenchymal Stem Cells Manifold Ways to Interact with Neurons. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23(10) [10.3390/ijms23105791].2022 Prospectively Assessing Serum Neurofilament Light Chain Levels As A Biomarker Of Paclitaxel-Induced Peripheral Neurotoxicity In Breast Cancer Patients Karteri, S., Bruna, J., Argyriou, A., Mariotto, S., Velasco, R., Alemany, M., et al. (2022). Prospectively Assessing Serum Neurofilament Light Chain Levels As A Biomarker Of Paclitaxel-Induced Peripheral Neurotoxicity In Breast Cancer Patients. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 27(2), 166-174 [10.1111/jns.12493].2022 Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. Alberti, P., Pozzi, E., Monza, L., Canta, A., Chiorazzi, A., Meregalli, C., et al. (2022). Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models.. In 12th Annual Meeting of the Italian-Association-for-the-Study-of-the-Peripheral-Nervous-System (ASNP) (pp.3-4). Wiley-Blackwell Publishing, Inc..2022 Chemotherapy Induced Peripheral Neurotoxicy: why should we care? Alberti, P., Cavaletti, G., Lucchese, E. (2022). Chemotherapy Induced Peripheral Neurotoxicy: why should we care?. In 12th Annual Meeting of the Italian-Association-for-the-Study-of-the-Peripheral-Nervous-System (ASNP) (pp.3-3).2022 International validation of the Erasmus GBS Respiratory Insufficiency Score Doets, A., Walgaard, C., Lingsma, H., Islam, B., Papri, N., Yamagishi, Y., et al. (2022). International validation of the Erasmus GBS Respiratory Insufficiency Score. ANNALS OF NEUROLOGY, 91(4 (April 2022)), 521-531 [10.1002/ana.26312].2022 Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score Doets, A., Lingsma, H., Walgaard, C., Islam, B., Papri, N., Davidson, A., et al. (2022). Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score. NEUROLOGY, 98(5), e518-e532 [10.1212/WNL.0000000000013139].2022 Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP Spina, E., Doneddu, P., Liberatore, G., Cocito, D., Fazio, R., Briani, C., et al. (2022). Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP. JOURNAL OF NEUROLOGY, 269(2), 907-912 [10.1007/s00415-021-10672-w].2022 Exercise and Neuropathy: Systematic Review with Meta-Analysis Streckmann, F., Balke, M., Cavaletti, G., Toscanelli, A., Bloch, W., Decard, B., et al. (2022). Exercise and Neuropathy: Systematic Review with Meta-Analysis. SPORTS MEDICINE, 52(5 (May 2022)), 1043-1065 [10.1007/s40279-021-01596-6].2022 Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database Liberatore, G., De Lorenzo, A., Giannotta, C., Manganelli, F., Filosto, M., Cosentino, G., et al. (2022). Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database. NEUROLOGICAL SCIENCES, 43(6), 3939-3947 [10.1007/s10072-021-05811-0].2022 Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values Arends, S., Drenthen, J., van den Bergh, P., Franssen, H., Hadden, R., Islam, B., et al. (2022). Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values. CLINICAL NEUROPHYSIOLOGY, 138(June 2022), 231-240 [10.1016/j.clinph.2021.12.014].2022 Rigosertib and cholangiocarcinoma: A cell cycle affair Malacrida, A., Cavaletti, G., Miloso, M. (2022). Rigosertib and cholangiocarcinoma: A cell cycle affair. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23(1) [10.3390/ijms23010213].2022 Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain Bloomingdale, P., Meregalli, C., Pollard, K., Canta, A., Chiorazzi, A., Fumagalli, G., et al. (2022). Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain. FRONTIERS IN PHARMACOLOGY, 12 [10.3389/fphar.2021.817236].2022 Clinical and preclinical features of eribulin-related peripheral neuropathy Tarasiuk, O., Cavaletti, G., Meregalli, C. (2022). Clinical and preclinical features of eribulin-related peripheral neuropathy. EXPERIMENTAL NEUROLOGY, 348(February 2022) [10.1016/j.expneurol.2021.113925].2022 MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines Malacrida, A., Di Domizio, A., Bentivegna, A., Cislaghi, G., Messuti, E., Tabano, S., et al. (2022). MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines. BIOLOGY, 11(1) [10.3390/biology11010070].2022 Rehabilitation, exercise, and related non-pharmacological interventions for chemotherapy-induced peripheral neurotoxicity: systematic review and evidence-based recommendations Tamburin, S., Park, S., Schenone, A., Mantovani, E., Hamedani, M., Alberti, P., et al. (2022). Rehabilitation, exercise, and related non-pharmacological interventions for chemotherapy-induced peripheral neurotoxicity: systematic review and evidence-based recommendations. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 171(March 2022) [10.1016/j.critrevonc.2021.103575].2022 Breast radiotherapy with kilovoltage photons and gold nanoparticles as radiosensitizer: An in vitro study Tudda, A., Donzelli, E., Nicolini, G., Semperboni, S., Bossi, M., Cavaletti, G., et al. (2022). Breast radiotherapy with kilovoltage photons and gold nanoparticles as radiosensitizer: An in vitro study. MEDICAL PHYSICS, 49(1), 568-578 [10.1002/mp.15348].2022 Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion Park, S., Tamburin, S., Schenone, A., Kleckner, I., Velasco, R., Alberti, P., et al. (2022). Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion. EXPERT REVIEW OF NEUROTHERAPEUTICS, 22(1), 65-76 [10.1080/14737175.2022.2018300].2022 Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: a prospective study Argyriou, A., Karteri, S., Bruna, J., Mariotto, S., Simo, M., Velissaris, D., et al. (2022). Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: a prospective study. SUPPORTIVE CARE IN CANCER, 30(2), 1807-1814 [10.1007/s00520-021-06509-x].2022 The neurophysiological lesson from the Italian CIDP database Spina, E., Doneddu, P., Liberatore, G., Cocito, D., Fazio, R., Briani, C., et al. (2022). The neurophysiological lesson from the Italian CIDP database. NEUROLOGICAL SCIENCES, 43(1), 573-582 [10.1007/s10072-021-05321-z].
2021
2021 DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY Fumagalli, G., Ballarini, E., Chiorazzi, A., Monza, L., Alberti, P., Oggioni, N., et al. (2021). DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY. In Abstracts of the Eleventh Annual Meeting of the Italian Association for the study of the Peripheral Nervous System (ASNP) 18–20 November 2021 Monza, Italy (pp.18-19). Wiley.2021 SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY Malacrida, A., Semperboni, S., Di Domizio, A., Pamioli, A., Airoldi, C., Meregalli, C., et al. (2021). SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY. In Abstracts of the Eleventh Annual Meeting of the Italian Association for the study of the Peripheral Nervous System (ASNP) 18–20 November 2021 Monza, Italy (pp.23-23). Wiley.2021 POTENTIAL FOR ENDOCANNABINOID SYSTEM IMPLICATION IN NEUROPATHIC PAIN AND INFLAMMATION IN BORTEZOMIB-INDUCED PERIPHERAL NEUROTOXICITY Meregalli, C., Serra, M., Boi, M., Carozzi, V., Chiorazzi, A., Oggioni, N., et al. (2021). POTENTIAL FOR ENDOCANNABINOID SYSTEM IMPLICATION IN NEUROPATHIC PAIN AND INFLAMMATION IN BORTEZOMIB-INDUCED PERIPHERAL NEUROTOXICITY. In Abstracts of the Eleventh Annual Meeting of the Italian Association for the study of the Peripheral Nervous System (ASNP) 18–20 November 2021 Monza, Italy (pp.25-25). Wiley.2021 INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING Semperboni, S., Malacrida, A., Monza, L., Rodriguez-Menendez, V., Pero, M., Rumora, A., et al. (2021). INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING. In Abstracts of the Eleventh Annual Meeting of the Italian Association for the study of the Peripheral Nervous System (ASNP) 18–20 November 2021 Monza, Italy (pp.35-36). Wiley.2021 RICOLINOSTAT INDUCES MICROTUBULE ACETYLATION AND NEURITE REGENERATION IN CELLULAR MODELS OF CHEMOTHERAPY-INDUCED NEUROPATHY Cartelli, D., Semperboni, S., Andelic, M., Malacrida, A., Nicolini, G., Lombardi, R., et al. (2021). RICOLINOSTAT INDUCES MICROTUBULE ACETYLATION AND NEURITE REGENERATION IN CELLULAR MODELS OF CHEMOTHERAPY-INDUCED NEUROPATHY. In Abstracts of the Eleventh Annual Meeting of the Italian Association for the study of the Peripheral Nervous System (ASNP) 18–20 November 2021 Monza, Italy (pp.8-9). Wiley.2021 ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY Quartu, M., Serra, M., Fumagalli, G., Oggioni, N., Boi, M., Marmiroli, P., et al. (2021). ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY. Intervento presentato a: XXXI Convegno GISN, Milano, 2021, milano.2021 INVESTIGATION OF AGING EFFECTS ON NERVE DAMAGE IN AN ANIMAL MODEL OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY Bonomo, R., Canta, A., Chiorazzi, A., Carozzi, V., Pozzi, E., Alberti, P., et al. (2021). INVESTIGATION OF AGING EFFECTS ON NERVE DAMAGE IN AN ANIMAL MODEL OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY. In Abstracts of the Eleventh Annual Meeting of the Italian Association for the study of the Peripheral Nervous System (ASNP) 18-20 November 2021 Monza, Italy (pp.S5-S5). Wiley-Blackwell Publishing, Inc. [10.1111/jns.12472].2021 Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study Luijten, L., Leonhard, S., van der Eijk, A., Doets, A., Appeltshauser, L., Arends, S., et al. (2021). Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study. BRAIN, 144(11), 3392-3404 [10.1093/brain/awab279].2021 Risk of Persistent Disability in Patients with Pediatric-Onset Multiple Sclerosis Baroncini, D., Simone, M., Iaffaldano, P., Brescia Morra, V., Lanzillo, R., Filippi, M., et al. (2021). Risk of Persistent Disability in Patients with Pediatric-Onset Multiple Sclerosis. JAMA NEUROLOGY, 78(6), 726-735 [10.1001/jamaneurol.2021.1008].2021 Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) Pero, M., Meregalli, C., Qu, X., Ji-Eun Shin, G., Kumar, A., Shorey, M., et al. (2021). Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) [Altro] [10.1073/pnas.2115637118].2021 Paclitaxel alters angiogenesis in the peripheral and central nervous system of neuropathic rats Carozzi, V., Ballarini, E., RODRIGUEZ MENENDEZ, V., Bossi, M., Pozzi, E., Cavaletti, G., et al. (2021). Paclitaxel alters angiogenesis in the peripheral and central nervous system of neuropathic rats. Intervento presentato a: 74 Congresso della Società Italiana di Anatomia ed Istologia, Bologna.2021 Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy Carozzi, V., Ballarini, E., Rodriguez-Menendez, V., Bossi, M., Pozzi, E., Canta, A., et al. (2021). Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy. Intervento presentato a: Undicesima riunione annuale dell'Associazione Italiana per lo Studio del Sistema Nervoso Periferico, Monza.2021 INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY Pozzi, E., Ballarini, E., Rodriguez Menendez, V., Alberti, P., Canta, A., Monza, L., et al. (2021). INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY. Intervento presentato a: 31st National Conference of the Italian Group for the Study of Neuromorphology “Gruppo Italiano per lo Studio della Neuromorfologia” G.I.S.N., Milano [10.4081/ejh.2021.3363].2021 Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity? Cavaletti, G., Marmiroli, P., Renn, C., Dorsey, S., Serra, M., Quartu, M., et al. (2021). Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity?. NEUROTHERAPEUTICS, 18(4), 2324-2336 [10.1007/s13311-021-01127-1].2021 Chapter 16. Impact of COVID-19 on pre-existing neurological diseases Alberti, P., Beretta, S., Brighina, L., Isella, V., Ferrarese, C. (2021). Chapter 16. Impact of COVID-19 on pre-existing neurological diseases. In A. Priori (a cura di), Neurology of COVID-19 (pp. 243-263). Milano : Milano University Press [10.54103/milanoup.57].2021 MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN Alberti, P., Canta, A., Chiorazzi, A., Meregalli, C., Monza, L., Pozzi, E., et al. (2021). MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN. In 31stNational Conference of the Italian Group for the Study of Neuromorphology “Gruppo Italiano per lo Studio della Neuromorfologia” G.I.S.N., meeting proceedings [10.4081/ejh.2021.3363].2021 Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy Eldridge, S., Scuteri, A., Jones, E., Cavaletti, G., Guo, L., Glaze, E. (2021). Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy. TOXICS, 9(11) [10.3390/toxics9110300].2021 Presenting International Chemotherapy induced peripheral neurotoxicity (CIPN) assessment and validation study (ICAVS) Alberti, P., Argyriou, A., Hyun, L., Cavaletti, G., ICAVS Study, G. (2021). Presenting International Chemotherapy induced peripheral neurotoxicity (CIPN) assessment and validation study (ICAVS). In Abstract book.2021 Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. Alberti, P., Malacrida, A., Ballarini, E., Nicolini, G., Semperboni, S., Canta, A., et al. (2021). Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity.. In Abstract book.2021 Practical Tips for a Rapid and Efficient CIPN Patient Evaluation Alberti, P. (2021). Practical Tips for a Rapid and Efficient CIPN Patient Evaluation. Intervento presentato a: November MASCC webinar, Virtual meeting.2021 Reversal of bortezomib-induced neurotoxicity by suvecaltamide, a selective T-type ca-channel modulator, in preclinical models Meregalli, C., Maricich, Y., Cavaletti, G., Canta, A., Carozzi, V., Chiorazzi, A., et al. (2021). Reversal of bortezomib-induced neurotoxicity by suvecaltamide, a selective T-type ca-channel modulator, in preclinical models. CANCERS, 13(19) [10.3390/cancers13195013].2021 Chemotherapy induced Peripheral Neurotoxicity (CIPN): why should we care? Alberti, P., Lucchese, E. (2021). Chemotherapy induced Peripheral Neurotoxicity (CIPN): why should we care?. In Meeting proceedings..2021 Prevention of chemotherapy-induced peripheral neuropathy (CIPN): Current clinical data and future directions Alberti, P., Steer, C. (2021). Prevention of chemotherapy-induced peripheral neuropathy (CIPN): Current clinical data and future directions. In M. Lustberg, C. Loprinzi (a cura di), Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy A MASCC Book (pp. 125-136). Springer [10.1007/978-3-030-78663-2_5].2021 Sodium/calcium exchanger (NCX): axonal damage as a consequence of functional disturbances. A new target for neuroprotection? Alberti, P., Ballarini, E., Canta, A., Scuteri, A., Marmiroli, P., Cavaletti, G. (2021). Sodium/calcium exchanger (NCX): axonal damage as a consequence of functional disturbances. A new target for neuroprotection?. In Abstract book del congresso SIAI 2021..2021 Nerve pathology in animal models of neuropathies Carozzi, V., Bolino, A., D'Antonio, M., Quattrini, A., Cavaletti, G. (2021). Nerve pathology in animal models of neuropathies. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 26(2), S61-S68 [10.1111/jns.12463].2021 Electrophysiological Assessments in Peripheral Nerves and Spinal Cord in Rodent Models of Chemotherapy-Induced Painful Peripheral Neuropathy Park, S., Renn, C., Lees, J., Dorsey, S., Cavaletti, G., Carozzi, V. (2021). Electrophysiological Assessments in Peripheral Nerves and Spinal Cord in Rodent Models of Chemotherapy-Induced Painful Peripheral Neuropathy. In J. Llorens, M. Barenys (a cura di), Neuromethods (pp. 133-161). Humana Press Inc. [10.1007/978-1-0716-1637-6_7].2021 Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: An international observational study Verboon, C., Harbo, T., Cornblath, D., Hughes, R., Van Doorn, P., Lunn, M., et al. (2021). Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: An international observational study. JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY, 92(10), 1080-1088 [10.1136/jnnp-2020-325815].2021 Assessment of Neurofilament Light Protein as a Serum Biomarker in Rodent Models of Toxic-Induced Peripheral Neuropathy Fumagalli, G., Cavaletti, G., Zetterberg, H., Meregalli, C. (2021). Assessment of Neurofilament Light Protein as a Serum Biomarker in Rodent Models of Toxic-Induced Peripheral Neuropathy. In J. Llorens, M. Barenys (a cura di), Neuromethods (pp. 267-275). Humana Press, Inc. [10.1007/978-1-0716-1637-6_12].2021 In vitro evaluation of rigosertib antitumoral and radiosensitizing effects against human cholangiocarcinoma cells Malacrida, A., Rigolio, R., Celio, L., Damian, S., Cavaletti, G., Mazzaferro, V., et al. (2021). In vitro evaluation of rigosertib antitumoral and radiosensitizing effects against human cholangiocarcinoma cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(15) [10.3390/ijms22158230].2021 Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research Monza, L., Fumagalli, G., Chiorazzi, A., Alberti, P. (2021). Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research. JOURNAL OF NEUROSCIENCE METHODS, 363(1 November 2021), 1-6 [10.1016/j.jneumeth.2021.109323].2021 The Italian law on body donation: A position paper of the Italian College of Anatomists De Caro, R., Boscolo-Berto, R., Artico, M., Bertelli, E., Cannas, M., Cappello, F., et al. (2021). The Italian law on body donation: A position paper of the Italian College of Anatomists. ANNALS OF ANATOMY, 238(November 2021) [10.1016/j.aanat.2021.151761].2021 Characteristics and patterns of pediatric chemotherapy-induced peripheral neuropathy: A systematic review Smith, E., Kuisell, C., Cho, Y., Kanzawa-Lee, G., Gilchrist, L., Park, S., et al. (2021). Characteristics and patterns of pediatric chemotherapy-induced peripheral neuropathy: A systematic review. CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 28 [10.1016/j.ctarc.2021.100420].2021 7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. Alberti, P., Bontempi, P., Gerevini, S., Napolitani, A., Daducci, A., Schiavi, S., et al. (2021). 7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model.. In Abstract book (pp.368-368).2021 Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy Induced Peripheral Neurotoxicity Alberti, P., Bernasconi, D., Cornblath, D., Jose Merkies, I., Park, S., Velasco, R., et al. (2021). Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy Induced Peripheral Neurotoxicity. NEUROLOGY, 97(7 (17 August 2021)), 660-672 [10.1212/WNL.0000000000012300].2021 Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect Malacrida, A., Semperboni, S., Di Domizio, A., Palmioli, A., Broggi, L., Airoldi, C., et al. (2021). Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect. SCIENTIFIC REPORTS, 11(1) [10.1038/s41598-021-89856-3].2021 Clinical and biochemical markers in CIPN: A reappraisal Bonomo, R., Cavaletti, G. (2021). Clinical and biochemical markers in CIPN: A reappraisal. REVUE NEUROLOGIQUE, 177(8), 890-907 [10.1016/j.neurol.2020.11.001].2021 Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice Meregalli, C., Bonomo, R., Cavaletti, G., Carozzi, V. (2021). Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice. NEUROSCIENCE LETTERS, 749(1 April 2021) [10.1016/j.neulet.2021.135739].2021 Targeting GRP receptor: design, synthesis and preliminary biological characterization of new non-peptide antagonists of bombesin Palmioli, A., Nicolini, G., Tripodi, F., Orsato, A., Ceresa, C., Donzelli, E., et al. (2021). Targeting GRP receptor: design, synthesis and preliminary biological characterization of new non-peptide antagonists of bombesin. BIOORGANIC CHEMISTRY, 109(April 2021) [10.1016/j.bioorg.2021.104739].2021 Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy Fumagalli, G., Monza, L., Cavaletti, G., Rigolio, R., Meregalli, C. (2021). Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy. FRONTIERS IN IMMUNOLOGY, 11 [10.3389/fimmu.2020.626687].2021 High-spatial-resolution three-dimensional imaging of human spinal cord and column anatomy with postmortem x-ray phase-contrast micro-CT Barbone, G., Bravin, A., Mittone, A., Grosu, S., Ricke, J., Cavaletti, G., et al. (2021). High-spatial-resolution three-dimensional imaging of human spinal cord and column anatomy with postmortem x-ray phase-contrast micro-CT. RADIOLOGY, 298(1), 135-146 [10.1148/RADIOL.2020201622].2021 Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? Liberatore, G., Manganelli, F., Doneddu, P., Cocito, D., Fazio, R., Briani, C., et al. (2021). Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria?. EUROPEAN JOURNAL OF NEUROLOGY, 28(2 (February 2021)), 620-629 [10.1111/ene.14545].2021 Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function Monza, L., Fumagalli, G., Chiorazzi, A., Alberti, P. (2021). Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function. BRAIN SCIENCES, 11(2), 1-11 [10.3390/brainsci11020139].2021 Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity Meregalli, C., Monza, L., Chiorazzi, A., Scali, C., Guarnieri, C., Fumagalli, G., et al. (2021). Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(3), 1-14 [10.3390/ijms22031058].2021 Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy Pero, M., Meregalli, C., Qu, X., Shin, G., Kumar, A., Shorey, M., et al. (2021). Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 118(4) [10.1073/pnas.2012685118].2021 Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register Lepore, V., Bosetti, C., Santucci, C., Iaffaldano, P., Trojano, M., Mosconi, P., et al. (2021). Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register. EUROPEAN JOURNAL OF NEUROLOGY, 28(2 (February 2021)), 567-578 [10.1111/ene.14589].2021 Genetic factors influencing the development of vincristine-induced neurotoxicity Pozzi, E., Fumagalli, G., Chiorazzi, A., Canta, A., Cavaletti, G. (2021). Genetic factors influencing the development of vincristine-induced neurotoxicity. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 17(2), 215-226 [10.1080/17425255.2021.1855141].2021 Chemotherapy induced peripheral neurotoxicity: Six essential articles for effective future research Alberti, P., Lehmann, H. (2021). Chemotherapy induced peripheral neurotoxicity: Six essential articles for effective future research. EXPERIMENTAL NEUROLOGY, 337(March 2021) [10.1016/j.expneurol.2020.113555].2021 Alterations of gut microbiota composition in post-finasteride patients: a pilot study Borgo, F., Macandog, A., Diviccaro, S., Falvo, E., Giatti, S., Cavaletti, G., et al. (2021). Alterations of gut microbiota composition in post-finasteride patients: a pilot study. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 44(6), 1263-1273 [10.1007/s40618-020-01424-0].
2020
2020 MALDI mass spectrometry imaging for in situ analysis of DRGs: Oxaliplatin modifies the tissue proteome Ballarini, E., Alberti, P., Carozzi, V., Rodriguez-Menendez, V., Cavaletti, G., Magni, F., et al. (2020). MALDI mass spectrometry imaging for in situ analysis of DRGs: Oxaliplatin modifies the tissue proteome. In Meeting proceedings. (pp.520-521). WILEY.2020 Metabolomics assessment in a mice model ofoxaliplatin-induced peripheral neurotoxicity Bonomo, R., Canta, A., Klein, T., Pozzi, E., Machado, V., Edene, C., et al. (2020). Metabolomics assessment in a mice model ofoxaliplatin-induced peripheral neurotoxicity. In 2020 Peripheral Nerve Society Virtual Event (pp.518-518). Wiley-Blackwell Publishing, Inc. [10.1111/jns.12416].2020 ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine Fontana, D., Mauri, M., Renso, R., Docci, M., Crespiatico, I., Rost, L., et al. (2020). ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine. NATURE COMMUNICATIONS, 11(1) [10.1038/s41467-020-19721-w].2020 ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine Fontana, D., Mauri, M., Renso, R., Docci, M., Crespiatico, I., Rost, L., et al. (2020). ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine. BLOOD, 136(Supplement_2), LBA-5-LBA-5 [10.1182/BLOOD-2020-143852].2020 SCALES: PERIPHERAL NERVES Alberti, P., Briani, C. (2020). SCALES: PERIPHERAL NERVES. In R.S. Wolfgang Grisold (a cura di), Effects of Cancer Treatment on the Nervous System, Volume 1 (pp. 198-232). Cambridge Scholars Publishing.2020 Guillain–Barré Syndrome Associated with COVID-19 Alberti, P., Beretta, S., Piatti, M., Karantzoulis, A., Piatti, M., Santoro, P., et al. (2020). Guillain–Barré Syndrome Associated with COVID-19. In Abstract book.2020 Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. Alberti, P., Ballarini, E., Canta, A., Chiorazzi, A., Fumagalli, G., Malacrida, A., et al. (2020). Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery.. In Meeting proceedings.2020 Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. Alberti, P., Malacrida, A., Semperboni, S., Meregalli, C., Ballarini, E., Cavaletti, G. (2020). Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection.. In Abstract book.2020 A possible biomarker for paclitaxel-induced peripheral neurotoxicity: Neurofilament light chain serum levels monitoring Alberti, P., Cicchiello, F., Riva, F., Cavaletti, G., Cazzaniga, M. (2020). A possible biomarker for paclitaxel-induced peripheral neurotoxicity: Neurofilament light chain serum levels monitoring. In Abstract book.2020 Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update Loprinzi, C., Lacchetti, C., Bleeker, J., Cavaletti, G., Chauhan, C., Hertz, D., et al. (2020). Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. JOURNAL OF CLINICAL ONCOLOGY, 38(28), 3325-3348 [10.1200/JCO.20.01399].2020 A review of novel biomarkers and imaging techniques for assessing the severity of chemotherapy-induced peripheral neuropathy Alberti, P. (2020). A review of novel biomarkers and imaging techniques for assessing the severity of chemotherapy-induced peripheral neuropathy. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 16(12), 1147-1158 [10.1080/17425255.2021.1842873].2020 Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification Dionisi, M., Ruffinatti, F., Riva, B., Lim, D., Canta, A., Meregalli, C., et al. (2020). Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 21(19), 1-15 [10.3390/ijms21197164].2020 Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy Doneddu, P., Cocito, D., Manganelli, F., Fazio, R., Briani, C., Filosto, M., et al. (2020). Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy. JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY, 91(10), 1092-1099 [10.1136/jnnp-2020-323615].2020 Effects of bortezomib-induced peripheral neuropathy on HSP27, HSP60 and HSP90 levels in the sciatic nerve Gammazza, M., Meregalli, C., Ballarini, E., Barone, R., Rappa, F., Paladino, L., et al. (2020). Effects of bortezomib-induced peripheral neuropathy on HSP27, HSP60 and HSP90 levels in the sciatic nerve. In in abstract book di MORFOLOGIA E DINTORNI.2020 Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity Fumagalli, G., Ballarini, E., Monza, L., Alberti, P., Oggioni, N., Cavaletti, G., et al. (2020). Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity. In Abstract book di "Morfologia e dintorni" 3° incontro nazionale 26 settembre 2020.2020 The relevance of morphology in experimental oxaliplatin-induced peripheral neurotoxicity Pozzi, E., Chiorazzi, A., Canta, A., Carozzi, V., Rodriguez-Menendez, V., Bossi, M., et al. (2020). The relevance of morphology in experimental oxaliplatin-induced peripheral neurotoxicity. Intervento presentato a: Morfologia e dintorni, 3° Incontro nazionale, online.2020 Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) Alberti, P., Ballarini, E., Canta, A., Chiorazzi, A., Fumagalli, G., Malacrida, A., et al. (2020). Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN). In Abstract book del 3° Incontro Morfologia e dintorni.2020 Establishing sample-preparation protocols for X-ray phase-contrast CT of rodent spinal cords: Aldehyde fixations and osmium impregnation Barbone, G., Bravin, A., Mittone, A., Kraiger, M., Hrabe de Angelis, M., Bossi, M., et al. (2020). Establishing sample-preparation protocols for X-ray phase-contrast CT of rodent spinal cords: Aldehyde fixations and osmium impregnation. JOURNAL OF NEUROSCIENCE METHODS, 339 [10.1016/j.jneumeth.2020.108744].2020 Emerging pharmacological strategies for the management of chemotherapy-induced peripheral neurotoxicity (CIPN), based on novel CIPN mechanisms Argyriou, A., Bruna, J., Park, S., Cavaletti, G. (2020). Emerging pharmacological strategies for the management of chemotherapy-induced peripheral neurotoxicity (CIPN), based on novel CIPN mechanisms. EXPERT REVIEW OF NEUROTHERAPEUTICS, 20(10), 1005-1016 [10.1080/14737175.2020.1796639].2020 Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy Liberatore, G., Giannotta, C., Sajeev, B., Morenghi, E., Terenghi, F., Gallia, F., et al. (2020). Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy. JOURNAL OF NEUROIMMUNOLOGY, 345 [10.1016/j.jneuroim.2020.577288].2020 SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy Milani, G., Montomoli, E., Bollati, V., Albetti, B., Bandi, C., Bellini, T., et al. (2020). SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 78, 161-163 [10.1016/j.ejim.2020.06.010].2020 Impact of environmental factors and physical activity on disability and quality of life in CIDP Doneddu, P., Bianchi, E., Cocito, D., Manganelli, F., Fazio, R., Filosto, M., et al. (2020). Impact of environmental factors and physical activity on disability and quality of life in CIDP. JOURNAL OF NEUROLOGY, 267(9), 2683-2691 [10.1007/s00415-020-09916-y].2020 Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents Listro, R., Stotani, S., Rossino, G., Rui, M., Malacrida, A., Cavaletti, G., et al. (2020). Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents. FRONTIERS IN CHEMISTRY, 8 [10.3389/fchem.2020.00495].2020 Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up Jordan, B., Margulies, A., Cardoso, F., Cavaletti, G., Haugnes, H., Jahn, P., et al. (2020). Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. ANNALS OF ONCOLOGY, 31(10), 1306-1319 [10.1016/j.annonc.2020.07.003].2020 Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: Data from the Italian CIDP database Liberatore, G., Manganelli, F., Cocito, D., Fazio, R., Briani, C., Filosto, M., et al. (2020). Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: Data from the Italian CIDP database. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 25(2), 152-161 [10.1111/jns.12378].2020 Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 Canta, A., Chiorazzi, A., Pozzi, E., Fumagalli, G., Monza, L., Meregalli, C., et al. (2020). Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594. ANTIOXIDANTS, 9(9), 1-2 [10.3390/antiox9090807].2020 The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity Pozzi, E., Fumagalli, G., Chiorazzi, A., Canta, A., Meregalli, C., Monza, L., et al. (2020). The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity. EXPERIMENTAL NEUROLOGY, 334 [10.1016/j.expneurol.2020.113458].2020 Management of oxaliplatin-induced peripheral sensory neuropathy Cavaletti, G., Marmiroli, P. (2020). Management of oxaliplatin-induced peripheral sensory neuropathy. CANCERS, 12(6) [10.3390/cancers12061370].2020 Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. Alberti, P., Ballarini, E., Canta, A., Chiorazzi, A., Fumagalli, G., Malacrida, A., et al. (2020). Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back.. In ABSTRACT BOOK.2020 Neurofilament light chain serum levels as a possible paclitaxel-induced peripheral neurotoxicity biomarker: pilot and feasibility study. Alberti, P., Cicchiello, F., Riva, F., Cazzaniga, M. (2020). Neurofilament light chain serum levels as a possible paclitaxel-induced peripheral neurotoxicity biomarker: pilot and feasibility study.. In MEETING PROCEEDINGS. (pp.481-482).2020 Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action Alberti, P., Semperboni, S., Malacrida, A., Canta, A., Chiorazzi, A., Pozzi, E., et al. (2020). Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action. In Virtual Conference of Peripheral-Nerve-Society (pp.488-489).2020 Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models Magli, S., Rossi, G., Risi, G., Bertini, S., Cosentino, C., Crippa, L., et al. (2020). Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models. FRONTIERS IN CHEMISTRY, 8 [10.3389/fchem.2020.00524].2020 Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity Canta, A., Chiorazzi, A., Pozzi, E., Fumagalli, G., Monza, L., Meregalli, C., et al. (2020). Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity. ANTIOXIDANTS, 9(7), 1-11 [10.3390/antiox9070594].2020 Metabolomics markers in Neurology: current knowledge and future perspectives for therapeutic targeting Bonomo, R., Cavaletti, G., Skene, D. (2020). Metabolomics markers in Neurology: current knowledge and future perspectives for therapeutic targeting. EXPERT REVIEW OF NEUROTHERAPEUTICS, 20(7), 725-738 [10.1080/14737175.2020.1782746].2020 Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice Huang, K., Leblanc, A., Uddin, M., Kim, J., Chen, M., Eisenmann, E., et al. (2020). Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice. THE JOURNAL OF CLINICAL INVESTIGATION, 130(9), 4601-4606 [10.1172/JCI136796].2020 Responsiveness and Minimal Clinical Important Difference (MCID) of the Total Neuropathy Score clinical and nurse versions in CIPN Alberti, P., Bernasconi, D., CI-PerinomS, (2020). Responsiveness and Minimal Clinical Important Difference (MCID) of the Total Neuropathy Score clinical and nurse versions in CIPN. In PNS MEETING ABSTRACT BOOK. (pp.502-502).2020 Role of neurophysiology in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Alberti, P. (2020). Role of neurophysiology in Chemotherapy-Induced Peripheral Neuropathy (CIPN). CLINICAL NEUROPHYSIOLOGY, 131(8 (August 2020)), 1964-1965 [10.1016/j.clinph.2020.04.013].2020 Approaches to measure paediatric chemotherapy-induced peripheral neurotoxicity: a systematic review Smith, E., Kuisell, C., Kanzawa-Lee, G., Bridges, C., Alberti, P., Cavaletti, G., et al. (2020). Approaches to measure paediatric chemotherapy-induced peripheral neurotoxicity: a systematic review. THE LANCET. HAEMATOLOGY, 7(5), 408-417 [10.1016/S2352-3026(20)30064-8].2020 Guillain-Barré syndrome related to COVID-19 infection Alberti, P., Beretta, S., Piatti, M., Karantzoulis, A., Piatti, M., Santoro, P., et al. (2020). Guillain-Barré syndrome related to COVID-19 infection. NEUROLOGY® NEUROIMMUNOLOGY & NEUROINFLAMMATION, 7(4) [10.1212/NXI.0000000000000741].2020 Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity Meregalli, C., Fumagalli, G., Alberti, P., Canta, A., Chiorazzi, A., Monza, L., et al. (2020). Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity. ARCHIVES OF TOXICOLOGY, 94(7), 2517-2522 [10.1007/s00204-020-02755-w].2020 Differential Contribution of Neuronal Uptake Transporters to Oxaliplatin Peripheral Neurotoxicity Huang, K., Leblanc, A., Alberti, P., Sprowl, J., Wang, J., Lustberg, M., et al. (2020). Differential Contribution of Neuronal Uptake Transporters to Oxaliplatin Peripheral Neurotoxicity. THE FASEB JOURNAL, 34(S1 Supplement: Experimental Biology 2020 Meeting Abstracts), 1-1 [10.1096/fasebj.2020.34.s1.03083].2020 On-cell Saturation Transfer Difference NMR study of Bombesin binding to GRP receptor Palmioli, A., Ceresa, C., Tripodi, F., La Ferla, B., Nicolini, G., Airoldi, C. (2020). On-cell Saturation Transfer Difference NMR study of Bombesin binding to GRP receptor. BIOORGANIC CHEMISTRY, 99 [10.1016/j.bioorg.2020.103861].2020 Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis Gironi, M., D. -C., G., Frigo., M., M, R., Clerici, M., Bazzini, C., et al. (2020). Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 41 [10.1016/j.msard.2020.102007].2020 3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line Malacrida, A., Rivara, M., Di Domizio, A., Cislaghi, G., Miloso, M., Zuliani, V., et al. (2020). 3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line. BIOORGANIC & MEDICINAL CHEMISTRY, 28(4) [10.1016/j.bmc.2019.115300].2020 Sex dimorphism in an animal model of multiple sclerosis: Focus on pregnenolone synthesis Giatti, S., Rigolio, R., Diviccaro, S., Falvo, E., Caruso, D., Garcia-Segura, L., et al. (2020). Sex dimorphism in an animal model of multiple sclerosis: Focus on pregnenolone synthesis. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 199 [10.1016/j.jsbmb.2020.105596].2020 Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors Potenzieri, A., Riva, B., Rigolio, R., Chiorazzi, A., Pozzi, E., Ballarini, E., et al. (2020). Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors. PAIN, 161(2), 405-415 [10.1097/j.pain.0000000000001722].2020 Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database Doneddu, P., Bianchi, E., Cocito, D., Manganelli, F., Fazio, R., Filosto, M., et al. (2020). Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database. EUROPEAN JOURNAL OF NEUROLOGY, 27(1 (January 2020)), 136-143 [10.1111/ene.14044].2020 Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets Fumagalli, G., Monfrini, M., Donzelli, E., Rodriguez-Menendez, V., Bonandrini, B., Figliuzzi, M., et al. (2020). Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets. INTERNATIONAL JOURNAL OF STEM CELLS, 13(1), 116-126 [10.15283/ijsc19094].2020 Methods for in vivo studies in rodents of chemotherapy induced peripheral neuropathy Bruna, J., Alberti, P., Calls-Cobos, A., Caillaud, M., Damaj, M., Navarro, X. (2020). Methods for in vivo studies in rodents of chemotherapy induced peripheral neuropathy. EXPERIMENTAL NEUROLOGY, 325(March 2020) [10.1016/j.expneurol.2019.113154].2020 Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity Alberti, P., Canta, A., Chiorazzi, A., Fumagalli, G., Meregalli, C., Monza, L., et al. (2020). Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity. NEUROPHARMACOLOGY, 164 [10.1016/j.neuropharm.2019.107905].